Fmr1 knockout mice: A model to study fragile X mental retardation

Male patients with fragile X syndrome lack FMR1 protein due to silencing of the FMR1 gene by amplification of a CGG repeat and subsequent methylation of the promoter region. The absence of FMR1 protein leads to mental retardation, aberrant behavior, and macroorchidism. Hardly anything is known about the physiological function of FMR1 and the pathological mechanisms leading to these symptoms. Therefore, we designed a knockout model for the fragile X syndrome in mice. The knockout mice lack normal Fmr1 protein and show macroorchidism, learning deficits, and hyperactivity. Consequently, this knockout mouse may serve as a valuable tool in the elucidation of the physiological role of FMR1 and the mechanisms involved in macroorchidism, abnormal behavior, and mental retardation.

[1]  G. Lynch,et al.  Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5 , 1986, Nature.

[2]  J. Sutcliffe,et al.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome , 1991, Cell.

[3]  B. Maes,et al.  Cognitive functioning and information processing of adult mentally retarded men with fragile-X syndrome. , 1994, American journal of medical genetics.

[4]  G. Turner,et al.  X-linked mental retardation associated with macro-orchidism. , 1975, Journal of medical genetics.

[5]  P. Finelli,et al.  Neurological findings in patients with the fragile-X syndrome. , 1985, Journal of neurology, neurosurgery, and psychiatry.

[6]  T. Kemper,et al.  Histoanatomic observations of the brain in early infantile autism , 1985, Neurology.

[7]  A. Berns,et al.  Requirement for a functional Rb-1 gene in murine development , 1992, Nature.

[8]  T. Webb,et al.  Is it possible to make a clinical diagnosis of the fragile X syndrome in a boy? , 1985, Archives of disease in childhood.

[9]  A. Scheibel,et al.  Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC Autopsy Research Report. , 1986, The American journal of psychiatry.

[10]  J. Opitz,et al.  Fragile X and autism: a multicenter survey. , 1986, American journal of medical genetics.

[11]  G. Fisch.  Is autism associated with the fragile X syndrome? , 1992, American journal of medical genetics.

[12]  F. Goodwin,et al.  Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines , 1980, Pharmacology Biochemistry and Behavior.

[13]  Alcino J. Silva,et al.  Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice. , 1992, Science.

[14]  K. Wisniewski,et al.  The Fra(X) syndrome: neurological, electrophysiological, and neuropathological abnormalities. , 1991, American journal of medical genetics.

[15]  Mario R. Capecchi,et al.  Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes , 1988, Nature.

[16]  D. Schlessinger,et al.  Fragile X genotype characterized by an unstable region of DNA , 1991, Science.

[17]  Allan Bradley,et al.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice , 1991, Cell.

[18]  J. Sutcliffe,et al.  Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox , 1991, Cell.

[19]  B. Oostra,et al.  Characterization and localization of the FMR-1 gene product associated with fragile X syndrome , 1993, Nature.

[20]  J. Knoll,et al.  Autism in fragile X females. , 1986, American journal of medical genetics.

[21]  A. Poustka,et al.  Enhanced expression of the murine FMR1 gene during germ cell proliferation suggests a special function in both the male and the female gonad. , 1993, Human molecular genetics.

[22]  E. Kandel,et al.  Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. , 1992, Science.

[23]  E. Courchesne,et al.  Hypoplasia of cerebellar vermal lobules VI and VII in autism. , 1988, The New England journal of medicine.

[24]  J. Mallet,et al.  Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain , 1993, Nature Genetics.

[25]  S. Ziesmer,et al.  Use of azide and hydrogen peroxide as an inhibitor for endogenous peroxidase in the immunoperoxidase method. , 1987, Journal of Histochemistry and Cytochemistry.

[26]  B. Hogan,et al.  Manipulating the mouse embryo: A laboratory manual , 1986 .

[27]  Ben A. Oostra,et al.  Absence of expression of the FMR-1 gene in fragile X syndrome , 1991, Cell.

[28]  W. Brown,et al.  Social gaze, social avoidance, and repetitive behavior in fragile X males: a controlled study. , 1988, American journal of mental retardation : AJMR.

[29]  David E. Housman,et al.  Tissue specific expression of FMR–1 provides evidence for a functional role in fragile X syndrome , 1993, Nature Genetics.

[30]  J. Mandel,et al.  The FMR–1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation , 1993, Nature Genetics.

[31]  S. Warren,et al.  FMR1 protein: conserved RNP family domains and selective RNA binding. , 1993, Science.

[32]  A. Reiss,et al.  Behavioral phenotype of fragile X syndrome: DSM-III-R autistic behavior in male children. , 1992, American journal of medical genetics.

[33]  E. Aylward,et al.  Neuroanatomy of fragile X syndrome: The posterior fossa , 1991, Annals of neurology.

[34]  J. Mandel,et al.  Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome , 1991, Science.

[35]  B. Oostra,et al.  A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome. , 1994, Human molecular genetics.

[36]  R. Nussbaum,et al.  The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein , 1993, Cell.

[37]  R. Morris.  Spatial Localization Does Not Require the Presence of Local Cues , 1981 .

[38]  E. Eichler,et al.  Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG–repeat , 1993, Nature Genetics.

[39]  G. Turner,et al.  X-linked mental retardation, macro-orchidism, and the Xq27 fragile site. , 1980, The Journal of pediatrics.

[40]  Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. , 1991 .

[41]  N. Archidiacono,et al.  Neuropsychological, psychiatric, and physical manifestations in 149 members from 18 fragile X families. , 1991, American journal of medical genetics.

[42]  J W Murakami,et al.  Reduced cerebellar hemisphere size and its relationship to vermal hypoplasia in autism. , 1989, Archives of neurology.

[43]  R. Morris,et al.  Place navigation impaired in rats with hippocampal lesions , 1982, Nature.

[44]  A L Reiss,et al.  Neuroanatomy in fragile X females: the posterior fossa. , 1991, American journal of human genetics.

[45]  Alcino J. Silva,et al.  Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice. , 1992, Science.